Patients face medicine shortages as private market buys up drugs


A critical year-long shortage of vital type 2 diabetes medicines is being driven partly by its demand as a weight loss aid, with figures suggesting more than half the prescribing for one drug is through the private market, HSJ has learned.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here